Essential Pharma Announces the Appointment of Emma Johnson as Chief Executive Officer Zug, Switzerland & Egham, UK - 24 May 2023 - Essential Pharma, an international specialty pharma company focused
UK marketing authorisations for IOPIDINE® (apraclonidine) fully transferred to Essential Pharma as change in UK NICE guidelines for glaucoma treatment.
UK marketing authorisations for IOPIDINE (apraclonidine) fully transferred to Essential Pharma as change in UK NICE guidelines for glaucoma treatment expected to lead to increase in patients' need
Essential Pharma Announces the Acquisition of HALDOL HALDOL is a first-generation 'typical' antipsychotic for the treatment of schizophrenia and some other psychiatric conditions The acquisition
Essential Pharma Announces the Acquisition of HALDOL® streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.